HIW vs MRVI
HIW: Highwoods Properties is an office REIT focused on owning and operating high-quality, amenitized workspaces in the most vibrant business districts across the Sun Belt and select markets. MRVI: Maravai LifeSciences provides essential nucleic acid synthesis reagents and bioprocessing analytical tools that underpin the development and manufacturing of next-generation vaccines and therapies.
Side-by-side fundamentals
| Metric | HIW | MRVI | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $30.98 | $7.81 | |
| Market cap | $3.4B | $2.0B | |
| P/E as of 2026-10-30 | 18.44 | n/a | |
| Net margin FY2025, SEC XBRL | +20.2% | -70.4% | HIW higher |
| Gross margin FY2025, SEC XBRL | n/a | +18.3% | |
| Operating margin FY2025, SEC XBRL | +67.6% | -115.9% | HIW higher |
| ROE FY2025, SEC XBRL | +6.8% | -35.1% | HIW higher |
| ROA FY2025, SEC XBRL | +2.6% | -17.0% | HIW higher |
| Debt / equity | 1.48 | 0.72 | MRVI lower |
| Revenue growth (YoY) FY2025, SEC XBRL | -2.4% | -28.3% | HIW higher |
| Revenue CAGR (3y) SEC XBRL | -0.9% | -40.5% | HIW higher |
| Dividend yield as of 2026-09-03 | 6.46% | n/a | |
| Dividend streak (yrs) SEC XBRL | 7 | 0 | HIW higher |
| Beta as of 2026-09-03 | 0.67 | 1.42 | |
| 1-year return as of 2026-10-30 close | +8.2% | +148.7% | MRVI higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.